News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
203,691 Results
Type
Article (9662)
Company Profile (43)
Press Release (193984)
Multimedia
Podcasts (11)
Webinars (5)
Section
Business (65084)
Career Advice (276)
Deals (12610)
Drug Delivery (29)
Drug Development (24864)
Employer Resources (69)
FDA (4661)
Job Trends (5223)
News (105360)
Policy (7907)
Tag
2027 Pharm Country Standard (1)
Academia (656)
Accelerated approval (11)
Adcomms (3)
Allergies (55)
Alliances (9495)
ALS (40)
Alzheimer's disease (512)
Antibody-drug conjugate (ADC) (103)
Approvals (4853)
Artificial intelligence (87)
Autoimmune disease (46)
Automation (8)
Bankruptcy (78)
Best Places to Work (4432)
BIOSECURE Act (2)
Biosimilars (48)
Biotechnology (26)
Bladder cancer (63)
Brain cancer (25)
Breast cancer (246)
Cancer (1696)
Cardiovascular disease (162)
Career advice (231)
Career pathing (7)
CAR-T (66)
CDC (11)
Cell therapy (194)
Cervical cancer (10)
Clinical research (22303)
Collaboration (343)
Company closure (2)
Compensation (808)
Complete response letters (13)
COVID-19 (812)
CRISPR (18)
C-suite (258)
Cystic fibrosis (59)
Data (2414)
Denatured (1)
Depression (37)
Diabetes (174)
Diagnostics (2028)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (63)
Drug pricing (46)
Drug shortages (8)
Duchenne muscular dystrophy (72)
Earnings (42238)
Editorial (12)
Employer branding (6)
Employer resources (58)
Events (29586)
Executive appointments (321)
FDA (5743)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (420)
Gene editing (39)
Generative AI (7)
Gene therapy (153)
GLP-1 (362)
Government (1170)
Grass and pollen (3)
Guidances (332)
Healthcare (6346)
HIV (20)
Huntington's disease (6)
IgA nephropathy (43)
Immunology and inflammation (72)
Immuno-oncology (15)
Indications (34)
Infectious disease (894)
Inflammatory bowel disease (59)
Inflation Reduction Act (4)
Influenza (34)
Intellectual property (51)
Interviews (41)
IPO (7847)
IRA (7)
Job creations (970)
Job search strategy (206)
JPM (15)
Kidney cancer (9)
Labor market (33)
Layoffs (179)
Leadership (4)
Legal (1503)
Liver cancer (24)
Longevity (2)
Lung cancer (245)
Lymphoma (172)
Machine learning (7)
Management (23)
Manufacturing (162)
MASH (51)
Medical device (4426)
Medtech (4443)
Mergers & acquisitions (5173)
Metabolic disorders (440)
Multiple sclerosis (63)
NASH (6)
Neurodegenerative disease (92)
Neuropsychiatric disorders (29)
Neuroscience (879)
NextGen: Class of 2026 (1687)
Non-profit (1256)
Now hiring (6)
Obesity (208)
Opinion (56)
Ovarian cancer (63)
Pain (47)
Pancreatic cancer (64)
Parkinson's disease (87)
Partnered (7)
Patents (100)
Patient recruitment (88)
Peanut (24)
People (14683)
Pharmaceutical (10)
Pharmacy benefit managers (4)
Phase 1 (5938)
Phase 2 (9642)
Phase 3 (8724)
Pipeline (2473)
Policy (46)
Postmarket research (796)
Preclinical (1916)
Press Release (9)
Prostate cancer (67)
Psychedelics (9)
Radiopharmaceuticals (91)
Rare diseases (272)
Real estate (1298)
Recruiting (30)
Regulatory (6488)
Reports (22)
Research institute (661)
Resumes & cover letters (50)
Rett syndrome (9)
RNA editing (6)
RSV (22)
Schizophrenia (43)
Series A (56)
Series B (42)
Service/supplier (3)
Sickle cell disease (31)
Special edition (10)
Spinal muscular atrophy (75)
Sponsored (12)
Startups (853)
Stomach cancer (4)
Supply chain (25)
Tariffs (33)
The Weekly (10)
Vaccines (328)
Venture capital (19)
Weight loss (147)
Women's health (17)
Worklife (4)
Date
Today (31)
Last 7 days (148)
Last 30 days (625)
Last 365 days (11146)
2026 (634)
2025 (11270)
2024 (11742)
2023 (13116)
2022 (30246)
2021 (17359)
2020 (15477)
2019 (13181)
2018 (10058)
2017 (9135)
2016 (8063)
2015 (9866)
2014 (6845)
2013 (5295)
2012 (5455)
2011 (5872)
2010 (4981)
Location
Africa (186)
Alabama (59)
Alaska (1)
Arizona (64)
Arkansas (4)
Asia (11759)
Australia (1872)
California (3947)
Canada (1208)
China (347)
Colorado (133)
Connecticut (142)
Delaware (148)
Europe (27745)
Florida (502)
Georgia (120)
Hawaii (1)
Idaho (12)
Illinois (222)
India (19)
Indiana (257)
Iowa (4)
Japan (162)
Kansas (39)
Kentucky (8)
Louisiana (10)
Maine (28)
Maryland (480)
Massachusetts (2634)
Michigan (105)
Minnesota (165)
Mississippi (2)
Missouri (34)
Montana (10)
Nebraska (7)
Nevada (32)
New Hampshire (29)
New Jersey (1176)
New Mexico (3)
New York (966)
North Carolina (455)
North Dakota (1)
Northern California (1991)
Ohio (60)
Oklahoma (2)
Oregon (6)
Pennsylvania (837)
Puerto Rico (3)
Rhode Island (3)
South America (291)
South Carolina (14)
Southern California (1600)
Tennessee (60)
Texas (590)
United States (13516)
Utah (100)
Virginia (77)
Washington D.C. (11)
Washington State (289)
West Virginia (2)
Wisconsin (23)
203,691 Results for "25".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark
J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action could improve on existing therapies.
January 5, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25
February 3, 2026
·
1 min read
Press Releases
Medline to report fourth quarter and full year 2025 results on February 25, 2026
January 29, 2026
·
1 min read
Press Releases
TempraMed Closes C$2.5 Million Fully Subscribed Private Placement
January 13, 2026
·
6 min read
Press Releases
Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25
November 4, 2025
·
4 min read
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
Also on Thursday, Zealand held its Capital Markets Day in London,
outlining the strategy
for its weight management franchise in the near-term, including launching five products by 2030.
December 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
January 5, 2026
·
1 min read
Drug pricing
UK Agrees To Boost Drug Spending by 25% To Avoid US Pharma Tariffs
U.K.-based pharmas will not face tariffs as long as Donald Trump is president, according to the agreement.
December 1, 2025
·
1 min read
·
Annalee Armstrong
Layoffs
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program
The strategic initiative will extend Metagenomi’s cash runway into the fourth quarter of 2027. That same year, the company expects to generate initial Phase I data for its lead asset MGX-001 in hemophilia A.
November 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Agilent Announces Cash Dividend of 25.5 Cents Per Share
November 20, 2025
·
1 min read
1 of 20,370
Next
